Dr. Jagsi Discusses the Benefits of Hypofractionated Radiotherapy for Breast Cancer

Video

Reshma Jagsi, MD, DPhil, associate professor, Department of Radiation Oncology, University of Michigan Health System, discusses the benefits of hypofractionated radiotherapy for patients with breast cancer.

Reshma Jagsi, MD, DPhil, associate professor, Department of Radiation Oncology, University of Michigan Health System, discusses the benefits of hypofractionated radiotherapy for patients with breast cancer.

Jagsi explains that hypofractionated radiaotherapy means giving radiation in larger doses per treatment so that treatment can be accomplished more quickly. An analysis conducted by Jagsi and her colleagues looked at the adoption of this approach over time because recent studies have established that hypofractionated radiotherapy are clinically equivalent to longer, standard courses of radiation therapy in the adjuvant treatment of many cases of early-stage breast cancer.

In selected patients, this approach may be a more convenient approach that is not inferior in terms of outcomes and might be preferable, Jagsi says.

Recent Videos
5 experts in this video
5 experts in this video
Screen capture of Seth Eisenberg, ASN, RN, OCN, BMTCN, on a video call with an Oncology Nursing News branded border around the frame
Image of a woman with glasses wearing a striped blouse and a black sweater in front of an Oncology Nursing News branded backdrop
Screenshot of Kiah Purcell, MSN, AGPCNP-BC, in a video call with the frame surrounded by an Oncology Nursing News branded border
Photo of Jamie Carroll, APRN, CNP, MSN, from a video call with an Oncology Nursing News branded border around the frame
5 experts in this video
Related Content